EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel antigen biomarker for detection of high-level of Loa loa microfilaremia

Sarah E Greene iD, Yuefang Huang, Kerstin Fischer, Bruce A Rosa, John Martin, Makedonka Mitreva, Devyn Yates, Samuel Wanji, Joseph Kamgno, Philip J Budge, Gary J Weil, Peter U Fischer

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Sarah E Greene und 11 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Division, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, United States of America. Hauptthemen laut MEDLINE: Loa, Loiasis, Antigens, Helminth, Enzyme-Linked Immunosorbent Assay. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation, Foundation for Barnes- Jewish Hospital, Foundation for Barnes-Jewish Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Loiasis is a disease caused by the nematode Loa loa . Serious adverse events sometimes occur in people with heavy L . loa microfilaremia after ivermectin treatment. In regions of Central Africa where loiasis is endemic, this significantly impedes global elimination programs for lymphatic filariasis and onchocerciasis that use mass distribution of ivermectin. Improved diagnostic tests to identify individuals at increased risk of serious adverse events could facilitate efforts to eliminate lymphatic filariasis and onchocerciasis in this region. Methods and findings We previously identified the L . loa protein Ll-Bhp-1 in loiasis patient sera. Here, we further characterize Ll-Bhp-1 and report development of an antigen capture ELISA to detect this antigen. This assay detected Ll-Bhp-1 in 74 of 116 (63.8%) loiasis patient sera. Ll-Bhp-1 levels were significantly correlated with L . loa microfilarial counts, and the sensitivity of the assay was highest for samples from people with high counts, (94% and 100% in people with ≥20,000 and ≥50,000 microfilaria per milliliter of blood, respectively). The antigen was not detected in 112 sera from people with other filarial infections, or in 34 control sera from the USA.

Conclusions

This Ll-Bhp-1 antigen assay is specific for loiasis, and highly sensitive for identifying people with high L . loa microfilarial counts who are at increased risk for serious adverse events after ivermectin treatment. L . loa antigen detection has the potential to facilitate loiasis mapping efforts and programs to eliminate lymphatic filariasis and onchocerciasis in Central Africa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LoaLoiasisAntigens, HelminthEnzyme-Linked Immunosorbent AssayBiomarkersHumansAnimalsAfrica, CentralMicrofilariaeSensitivity and SpecificityIvermectinFemaleMale

Substanzen

Antigens, HelminthBiomarkersIvermectin

Autor:innen und Institutionen

  • Infectious Diseases Division, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, United States of America.
  • Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
  • Department of Genetics, Washington University School of Medicine, St Louis, Missouri, United States of America.
  • McDonnell Genome Institute, Washington University School of Medicine, St Louis, Missouri, United States of America.
  • Parasites and Vector Biology research unit (PAVBRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
  • Research Foundation for Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon.

ORCID-Profile: Sarah E Greene

Förderung

  • Bill and Melinda Gates Foundation
  • Foundation for Barnes- Jewish Hospital
  • Foundation for Barnes-Jewish Hospital

Zitieren

APA

Greene, S. E., Huang, Y., Fischer, K., Rosa, B. A., Martin, J., Mitreva, M., Yates, D., Wanji, S., Kamgno, J., Budge, P. J., Weil, G. J., & Fischer, P. U. (2024). A novel antigen biomarker for detection of high-level of Loa loa microfilaremia. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012461

Vancouver

Greene SE, Huang Y, Fischer K, Rosa BA, Martin J, Mitreva M, et al. A novel antigen biomarker for detection of high-level of Loa loa microfilaremia. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012461

BibTeX
@article{Greene2024,
  author = {Greene, Sarah E and Huang, Yuefang and Fischer, Kerstin and Rosa, Bruce A and Martin, John and Mitreva, Makedonka and Yates, Devyn and Wanji, Samuel and Kamgno, Joseph and Budge, Philip J and Weil, Gary J and Fischer, Peter U},
  title = {A novel antigen biomarker for detection of high-level of Loa loa microfilaremia},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012461}
}
Kostenlos starten →